How can technology coupled with science help create better drugs with faster timelines? Join Credit Suisse’s Equity Capital Markets and Banking Life Sciences teams on Tuesday, March 23rd for our first virtual event exploring this topic through panel discussions and the opportunity for one-on-one meetings with investors.
A select group of companies will participate, including AbCellera, Schrodinger, Relay Therapeutics, Atomwise, Exscientia, and Insitro. Participating companies should indicate if they wish to make themselves available for 1x1 meetings with investors. Credit Suisse will organize the 1x1 meetings.